ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EAH Eco Animal Health Group Plc

94.00
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 94.00 95.00 99.00 0.00 07:32:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chem,fertlizer Minrl Mng,nec 85.31M 1.01M 0.0149 63.09 63.68M

ECO Animal Health Statement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation d...

03/12/2018 7:00am

UK Regulatory


Eco Animal Health (LSE:EAH)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Eco Animal Health Charts.
 
TIDMEAH 
 
 

ECO Animal Health Group plc

 

(AIM: EAH)

 

ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal

 

ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered a development and licensing deal with Agrinnovation and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., State of Israel.

 

This deal, based on a number of milestone payments, allows ECO to licence patented research related innovations leading to the development of a unique long acting injectable florfenicol product to treat swine bacterial respiratory disease with a single dose. Florfenicol is an antimicrobial used only in veterinary medicine and the product will complement both the spectrum of activity and the oral route of administration of Aivlosin ®, ECO's patented molecule for the treatment of economically important diseases in pigs and poultry.

 

Peter Lawrence, Non-executive Chairman of ECO Animal Health Group plc said, "Recent market research has indicated that treatment for respiratory disease accounts for over 40% of antimicrobial treatments in finishing pigs. We are delighted to have entered this collaboration with Agrinnovation ".

 

Dr. Ido Schechter, Agrinnovation CEO said, "We are excited to enter this collaboration with ECO, which underscores the promise of agricultural research at Hebrew University and supports our vision of sustainable agriculture around the world through collaborations between industry and academic organizations."

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

Contacts:

 

ECO Animal Health Group plc

 
Peter Lawrence                        020 8336 6190 
Marc Loomes                           020 8447 6906 
Spiro Financial 
Anthony Spiro                         020 8336 6196 
N+1 Singer (Nominated Adviser)        020 7496 3000 
Mark Taylor, Brough Ransom 
Peel Hunt LLP (Joint Broker) 
James Steel, Dr Christopher Golden    020 7418 8900 
 
 

-----------------------------------------------------

 

About ECO Animal Health Ltd

 

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

 

About Agrinnovation (Yissum) L.P.

 

Agrinnovation is a limited partnership affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., State of Israel, entitled to invest in, develop and commercialise projects in the field of veterinary medicine based on inventions generated by scientists of the University.

 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20181202005043/en/

 
This information is provided by Business Wire 
 
 

(END) Dow Jones Newswires

December 03, 2018 02:00 ET (07:00 GMT)

1 Year Eco Animal Health Chart

1 Year Eco Animal Health Chart

1 Month Eco Animal Health Chart

1 Month Eco Animal Health Chart

Your Recent History

Delayed Upgrade Clock